For this groundbreaking contribution to finding treatment for more then 8,000 diseases  that can be traced back to gene defect, Felix Lansing was awarded second place in the Deutscher Studienpreis of the Körber Foundation. The award ceremony took place in … Continue reading →

Dr Felix Lansing has made a groundbreaking contribution to cell and gene therapy, for which he was awarded 2nd place in the Deutscher Studienpreis by the Körber Foundation. “In my dissertation,” outlines Dr Lansing, “I developed a new molecular scalpel … Continue reading →

RecTech GmbH is a brand new start-up focused on developing designer recombinases for precision genome editing. Supported by the BMBF GO-Bio programme, the lab of Frank Buchholz founded the company to translate its scientific findings into a translational pipeline. @RecTech_Dresden … Continue reading →

The research team led by Prof. Frank Buchholz at the Carl Gustav Carus Medical Faculty of the Technical University of Dresden has succeeded in developing an enzyme that can efficiently and specifically correct a gene mutation in the Factor VIII … Continue reading →

mdr Sachsen podcast broadcasts interview with Prof. Dr. Frank Buchholz on communication in science On 18 January 2022, mdr Sachsen published a podcast on the topic “Is there a therapy for Long Covid?” in which Prof. Dr. Frank Buchholz comments … Continue reading →